Isolated cell-bound membrane vesicles (CBMVs) as a novel class of drug nanocarriers
Open Access
- 6 May 2020
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 18 (1) , 1-16
Abstract
Background: Cell-bound membrane vesicles (CBMVs) are a type of membrane vesicles different from the well-known extracellular vesicles (EVs). In recent years, the applications of EVs as drug delivery systems have been studied widely. A question may arise whether isolated CBMVs also have the possibility of being recruited as a drug delivery system or nanocarrier? Methods: To test the possibility, CBMVs were isolated/purified from the surfaces of cultured endothelial cells, loaded with a putative antitumor drug doxorubicin (Dox), and characterized. Subsequently, cellular experiments and animal experiments using mouse models were performed to determine the in vitro and in vivo antitumor effects of Dox-loaded CBMVs (Dox-CBMVs or Dox@CBMVs), respectively. Results: Both Dox-free and Dox-loaded CBMVs were globular-shaped and nanometer-sized with an average diameter of ~ 300–400 nm. Dox-CBMVs could be internalized by cells and could kill multiple types of cancer cells. The in vivo antitumor ability of Dox-CBMVs also was confirmed. Moreover, Quantifications of blood cells (white blood cells and platelets) and specific enzymes (aspartate aminotransferase and creatine kinase isoenzymes) showed that Dox-CBMVs had lower side effects compared with free Dox. Conclusions: The data show that the CBMV-entrapped Doxorubicin has the antitumor efficacy with lower side effects. This study provides evidence supporting the possibility of isolated cell-bound membrane vesicles as a novel drug nanocarrier.Keywords
Funding Information
- National Natural Science Foundation of China (31760320)
- Natural Science Foundation of Jiangxi Province (20161ACB20001)
This publication has 40 references indexed in Scilit:
- As we wait: coping with an imperfect nomenclature for extracellular vesiclesJournal of Extracellular Vesicles, 2013
- Cooperation between β‐ and γ‐cytoplasmic actins in the mechanical regulation of endothelial microparticle formationThe FASEB Journal, 2012
- Classification, Functions, and Clinical Relevance of Extracellular VesiclesPharmacological Reviews, 2012
- Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug deliveryJournal of Controlled Release, 2012
- The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunitiesBiochemical Pharmacology, 2012
- Exosome mimetics: a novel class of drug delivery systemsInternational Journal of Nanomedicine, 2012
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Targeted delivery of doxorubicin using stealth liposomes modified with transferrinInternational Journal of Pharmaceutics, 2009
- Dosing time dependency of doxorubicin-induced cardiotoxicity and bone marrow toxicity in ratsJournal of Pharmacy and Pharmacology, 2003
- In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulantJournal of Clinical Investigation, 1999